|
SORT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.825800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.967700E-04 |
| Normal-vs-Stage2 |
3.732800E-01 |
| Normal-vs-Stage3 |
7.049300E-04 |
| Normal-vs-Stage4 |
6.582100E-03 |
| Stage1-vs-Stage2 |
2.301800E-02 |
| Stage1-vs-Stage3 |
7.686200E-01 |
| Stage1-vs-Stage4 |
9.363400E-01 |
| Stage2-vs-Stage3 |
2.853700E-02 |
| Stage2-vs-Stage4 |
9.299500E-02 |
| Stage3-vs-Stage4 |
7.853200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.033260E-04 |
| Normal-vs-AfricanAmerican |
7.221200E-01 |
| Normal-vs-Asian |
1.903370E-03 |
| Caucasian-vs-AfricanAmerican |
1.742410E-02 |
| Caucasian-vs-Asian |
9.496400E-01 |
| AfricanAmerican-vs-Asian |
2.213800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.599500E-04 |
| Normal-vs-Female |
1.497830E-03 |
| Male-vs-Female |
2.655600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.844640E-04 |
| Normal-vs-Age(41-60Yrs) |
3.263800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.257740E-02 |
| Normal-vs-Age(81-100Yrs) |
1.152460E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.960800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.005800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.862800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.154800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.224600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.297630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.980100E-02 |
| Classical-VS-Follicular |
6.876400E-03 |
| Classical-VS-Other |
9.098200E-01 |
| Classical-VS-Normal |
3.356800E-04 |
| Tall-VS-Follicular |
1.301700E-03 |
| Tall-VS-Other |
4.838400E-01 |
| Tall-VS-Normal |
8.37009999999916E-05 |
| Follicular-VS-Other |
3.700200E-01 |
| Follicular-VS-Normal |
2.806200E-01 |
| Other-VS-Normal |
1.368150E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.618100E-03 |
| Normal-vs-N1 |
2.45269999999964E-05 |
| N0-vs-N1 |
3.426500E-02 |
|
|
